Sage Private Wealth Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.25M Buy
1,363
+113
+9% +$115K 0.63% 15
2025
Q4
$1.34M Sell
1,250
-27
-2% -$25.8K 0.72% 16
2025
Q3
$974K Sell
1,277
-239
-16% -$178K 0.54% 21
2025
Q2
$1.18M Sell
1,516
-13
-0.9% -$10.1K 0.76% 14
2025
Q1
$1.26M Sell
1,529
-14
-0.9% -$11.6K 0.96% 10
2024
Q4
$1.19M Sell
1,543
-95
-6% -$78.7K 0.89% 11
2024
Q3
$1.45M Sell
1,638
-33
-2% -$29.7K 1.14% 8
2024
Q2
$1.51M Sell
1,671
-59
-3% -$47.2K 1.27% 8
2024
Q1
$1.35M Buy
1,730
+19
+1% +$13.5K 1.08% 12
2023
Q4
$997K Buy
+1,711
New +$999K 0.89% 12

Other funds holding LLY

Sage Private Wealth Group's LLY Position: Q1 2026 in Review

Sage Private Wealth Group increased its Eli Lilly (LLY) stake by 9% in Q1 2026, buying an estimated $115K and bringing the position to 1,363 shares worth $1.25M. The position accounts for 0.63% of the portfolio, ranked #15.

Sage Private Wealth Group first reported a position in LLY in Q4 2023 and has held it in 10 quarters since. The position peaked at $1.51M in Q2 2024. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Sage Private Wealth Group held 1,363 shares of Eli Lilly worth $1.25M as of Q1 2026.
  • Sage Private Wealth Group bought 113 Eli Lilly shares in Q1 2026, an estimated $115K.
  • Eli Lilly made up 0.63% of Sage Private Wealth Group's portfolio in Q1 2026, its #15 holding.
  • Sage Private Wealth Group first reported a position in Eli Lilly in Q4 2023 and has held it in 10 quarters since.
  • Sage Private Wealth Group's Eli Lilly position peaked at $1.51M in Q2 2024.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Sage Private Wealth Group's 13F filing for Q1 2026, filed 1 May 2026.